Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Sep 24, 2025

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

80 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MYX Mayne Pharma Group	AU$5.13	3.0%	12.3%	AU$416.8m	AU$6.75	PS1x	E130.4%	n/a
CYP Cynata Therapeutics	AU$0.20	7.9%	-4.7%	AU$48.7m	n/a	PS25.8x	E125.7%	n/a
ACR Acrux	AU$0.014	0%	-75.0%	AU$5.7m	n/a	PS4.8x	E121.1%	0%
BOT Botanix Pharmaceuticals	AU$0.15	20.0%	-60.5%	AU$294.2m	n/a	PS50.8x	E91.3%	n/a
ARX Aroa Biosurgery	AU$0.68	-2.2%	21.4%	AU$234.6m	n/a	PS3.1x	E86.2%	n/a
TRJ Trajan Group Holdings	AU$0.74	0%	-40.8%	AU$112.9m	AU$1.23	PB1.1x	E83.7%	n/a
MVP Medical Developments International	AU$0.67	-0.7%	55.8%	AU$75.5m	AU$2.27	PE803x	E67.1%	0%
VFY Vitrafy Life Sciences	AU$1.25	7.8%	n/a	AU$79.8m	AU$2.19	PS76.2x	E63.8%	n/a
MSB Mesoblast	AU$2.49	6.0%	128.4%	AU$3.2b	AU$3.49	PS122.1x	E56.5%	n/a
OPT Opthea	AU$0.60	0%	23.7%	AU$738.8m	AU$1.09	PS2307.7x	E56.4%	n/a
GSS Genetic Signatures	AU$0.27	3.9%	-60.4%	AU$60.2m	n/a	PS3x	E51.8%	n/a
TLX Telix Pharmaceuticals	AU$15.38	12.6%	-25.9%	AU$5.2b	AU$27.40	PE316.3x	E47.7%	n/a
CU6 Clarity Pharmaceuticals	AU$3.74	5.9%	-57.0%	AU$1.4b	AU$7.48	PS147x	E46.1%	n/a
IMM Immutep	AU$0.26	2.0%	-26.1%	AU$374.3m	AU$1.14	PS74.2x	E42.1%	n/a
RAD Radiopharm Theranostics	AU$0.029	-14.7%	-6.5%	AU$68.6m	n/a	PS5.5x	E41.9%	n/a
PYC PYC Therapeutics	AU$1.01	12.3%	-44.2%	AU$586.2m	AU$3.49	PS24.9x	E33.8%	n/a
CUV Clinuvel Pharmaceuticals	AU$11.20	-2.8%	-21.7%	AU$561.4m	AU$23.87	PE15.5x	E26.2%	0.4%
EZZ EZZ Life Science Holdings	AU$2.21	1.4%	-41.2%	AU$104.3m	AU$5.00	PE15.5x	E25.4%	1.8%
RCE Recce Pharmaceuticals	AU$0.41	6.4%	-23.1%	AU$120.0m	AU$2.62	PS16x	E24.9%	n/a
ATH Alterity Therapeutics	AU$0.011	0%	266.7%	AU$119.6m	n/a	PS22x	E21.7%	n/a
CSL CSL	AU$197.99	-0.2%	-32.0%	AU$95.8b	AU$282.27	PE21x	E11.6%	2.2%
NEU Neuren Pharmaceuticals	AU$19.75	-1.9%	37.6%	AU$2.5b	AU$24.73	PE16.7x	E5.4%	n/a
RAC Race Oncology	AU$3.11	21.0%	71.3%	AU$540.5m	AU$6.37	PS89.4x	E-1.0%	n/a
TTX Tetratherix	AU$4.15	-4.2%	n/a	AU$208.9m	AU$5.03	PS198.4x	E-1.2%	n/a

Page 1 of 4